{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:04:12Z","timestamp":1789725852074,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM146701"],"award-info":[{"award-number":["R35GM146701"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijantimicag.2026.107809","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:55:39Z","timestamp":1776282939000},"page":"107809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Model-informed cefepime dosing in paediatric patients receiving continuous renal replacement therapy"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-3717","authenticated-orcid":false,"given":"Ronaldo","family":"Morales Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Reinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Diseroad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-8499","authenticated-orcid":false,"given":"Sonya","family":"Tang Girdwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1218-8293","authenticated-orcid":false,"given":"H. Rhodes","family":"Hambrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107809_bib0001","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/PCC.0000000000001806","article-title":"Mortality of critically ill children requiring continuous renal replacement therapy: effect of fluid overload, underlying disease, and timing of initiation","volume":"20","author":"Cortina","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0002","article-title":"Clinical outcomes of renal replacement therapy in paediatric acute kidney injury: a 10-year retrospective observational study","volume":"9","author":"Voraruth","year":"2022","journal-title":"Glob Pediatr Health"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0003","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign International guidelines for the management of Septic shock and sepsis-associated organ dysfunction in children","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0004","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/antibiotics12040681","article-title":"The current status and future perspectives of beta-lactam therapeutic drug monitoring in critically ill patients","volume":"12","author":"Novy","year":"2023","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/08971900221125000","article-title":"Cefepime-associated neurotoxicity in a paediatric patient with stage V chronic kidney disease","volume":"37","author":"Hambrick","year":"2024","journal-title":"J Pharm Pr"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/bcp.70120","article-title":"Unveiling predisposing factors for cefepime-induced neurotoxicity: a systematic review and meta-analysis","author":"Hardi","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0007","doi-asserted-by":"crossref","first-page":"e02006","DOI":"10.1128\/AAC.02006-18","article-title":"Akcan Arikan A. Cefepime pharmacokinetics in critically ill paediatric patients receiving continuous renal replacement therapy","volume":"63","author":"Stitt","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0008","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1093\/jac\/dkad192","article-title":"Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy","volume":"78","author":"Pavia","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0009","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40560-024-00752-0","article-title":"Tang Girdwood S. Monte Carlo simulations of cefepime in children receiving continuous kidney replacement therapy support continuous infusions for target attainment","volume":"12","author":"Hambrick","year":"2024","journal-title":"J Intensive Care"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70438","article-title":"Building a beta-lactam model-informed precision dosing service in a quaternary care children\u2019s hospital","volume":"18","author":"Tang Girdwood","year":"2025","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0011","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40560-024-00752-0","article-title":"Tang Girdwood S. Monte Carlo simulations of cefepime in children receiving continuous kidney replacement therapy support continuous infusions for target attainment","volume":"12","author":"Hambrick","year":"2024","journal-title":"J Intensive Care"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0012","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jcph.1773","article-title":"Demonstrating feasibility of an opportunistic sampling approach for pharmacokinetic studies of \u03b2-lactam antibiotics in critically ill children","volume":"61","author":"Tang Girdwood","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0013","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s40262-022-01137-y","article-title":"Clinical pharmacokinetics and pharmacodynamics of Cefepime","volume":"61","author":"Pais","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0014","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1128\/AAC.02592-15","article-title":"Population pharmacokinetic assessment and pharmacodynamic implications of paediatric cefepime dosing for susceptible-dose-dependent organisms","volume":"60","author":"Shoji","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0015","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2026.107809_bib0016","doi-asserted-by":"crossref","first-page":"dlae030","DOI":"10.1093\/jacamr\/dlae030","article-title":"Covariates in population pharmacokinetic studies of critically ill adults receiving \u03b2-lactam antimicrobials: a systematic review and narrative synthesis","volume":"6","author":"Hansel","year":"2024","journal-title":"JAC Antimicrob Resist"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:25:17Z","timestamp":1780626317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0924857926000981"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107809","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Model-informed cefepime dosing in paediatric patients receiving continuous renal replacement therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107809"}}